Case Reports
doi: 10.1176/appi.ajp.157.6.1021-a.
Exacerbation of psychosis by phenylpropanolamine
- PMID: 10831490
- DOI: 10.1176/appi.ajp.157.6.1021-a
Item in Clipboard
Case Reports
Exacerbation of psychosis by phenylpropanolamine
Am J Psychiatry.
2000 Jun.
No abstract available
Similar articles
-
Psychotic episodes associated with the use of common proprietary decongestants.Am J Psychiatry. 1966 Oct;123(4):484-7. doi: 10.1176/ajp.123.4.484. Am J Psychiatry. 1966. PMID: 4163280 No abstract available.
-
Nasal decongestants and paranoid psychosis.Br J Psychiatry. 1970 Oct;117(539):439-40. doi: 10.1192/bjp.117.539.439. Br J Psychiatry. 1970. PMID: 4098187 No abstract available.
-
Nitrous oxide: a psychotogenic agent.Compr Psychiatry. 1975 Mar-Apr;16(2):185-8. doi: 10.1016/0010-440x(75)90065-6. Compr Psychiatry. 1975. PMID: 1120420 No abstract available.
-
Psychiatric reactions produced by respiratory drugs.Psychosomatics. 1985 Jul;26(7):605-8, 615-6. doi: 10.1016/S0033-3182(85)72823-X. Psychosomatics. 1985. PMID: 2410944 Review. No abstract available.
-
Methamphetamine psychosis: insights from the past.Addiction. 2018 Aug;113(8):1522-1527. doi: 10.1111/add.14170. Epub 2018 Mar 8. Addiction. 2018. PMID: 29516555 Review.
Cited by
-
Safety of drug therapies used for weight loss and treatment of obesity.Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001. Drug Saf. 2006. PMID: 16569079 Review.
-
The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.Neuromolecular Med. 2013 Mar;15(1):159-68. doi: 10.1007/s12017-012-8206-x. Epub 2012 Nov 20. Neuromolecular Med. 2013. PMID: 23179670
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
